192 related articles for article (PubMed ID: 28391065)
1. Novel lipoproteoplex delivers Keap1 siRNA based gene therapy to accelerate diabetic wound healing.
Rabbani PS; Zhou A; Borab ZM; Frezzo JA; Srivastava N; More HT; Rifkin WJ; David JA; Berens SJ; Chen R; Hameedi S; Junejo MH; Kim C; Sartor RA; Liu CF; Saadeh PB; Montclare JK; Ceradini DJ
Biomaterials; 2017 Jul; 132():1-15. PubMed ID: 28391065
[TBL] [Abstract][Full Text] [Related]
2. Restoration of Nrf2 Signaling Normalizes the Regenerative Niche.
Soares MA; Cohen OD; Low YC; Sartor RA; Ellison T; Anil U; Anzai L; Chang JB; Saadeh PB; Rabbani PS; Ceradini DJ
Diabetes; 2016 Mar; 65(3):633-46. PubMed ID: 26647385
[TBL] [Abstract][Full Text] [Related]
3. Milk-derived exosomes carrying siRNA-KEAP1 promote diabetic wound healing by improving oxidative stress.
Xiang X; Chen J; Jiang T; Yan C; Kang Y; Zhang M; Xiang K; Guo J; Jiang G; Wang C; XiangXu ; Yang X; Chen Z
Drug Deliv Transl Res; 2023 Sep; 13(9):2286-2296. PubMed ID: 36749479
[TBL] [Abstract][Full Text] [Related]
4. Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds.
Rabbani PS; Ellison T; Waqas B; Sultan D; Abdou S; David JA; Cohen JM; Gomez-Viso A; Lam G; Kim C; Thomson J; Ceradini DJ
Diabetes Res Clin Pract; 2018 May; 139():11-23. PubMed ID: 29476889
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
[TBL] [Abstract][Full Text] [Related]
6. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
7. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
8. Constructing Nucleic Acid Delivering Lipoproteoplexes from Coiled-Coil Supercharged Protein and Cationic Liposomes.
Thomas J; Sun J; Montclare JK
Methods Mol Biol; 2024; 2720():191-207. PubMed ID: 37775667
[TBL] [Abstract][Full Text] [Related]
9. Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat.
Amadio M; Pascale A; Cupri S; Pignatello R; Osera C; D Agata V; D Amico AG; Leggio GM; Ruozi B; Govoni S; Drago F; Bucolo C
Pharmacol Res; 2016 Sep; 111():713-720. PubMed ID: 27475885
[TBL] [Abstract][Full Text] [Related]
10. Dietary prenylated flavonoid xanthohumol alleviates oxidative damage and accelerates diabetic wound healing via Nrf2 activation.
Lu X; Liu M; Dong H; Miao J; Stagos D; Liu M
Food Chem Toxicol; 2022 Feb; 160():112813. PubMed ID: 34999176
[TBL] [Abstract][Full Text] [Related]
11. Silencing TNFα with lipidoid nanoparticles downregulates both TNFα and MCP-1 in an in vitro co-culture model of diabetic foot ulcers.
Kasiewicz LN; Whitehead KA
Acta Biomater; 2016 Mar; 32():120-128. PubMed ID: 26689461
[TBL] [Abstract][Full Text] [Related]
12. Transdermal Delivery of Small Interfering RNA with Elastic Cationic Liposomes in Mice.
Hattori Y; Date M; Arai S; Kawano K; Yonemochi E; Maitani Y
J Pharm (Cairo); 2013; 2013():149695. PubMed ID: 26555966
[TBL] [Abstract][Full Text] [Related]
13. Charge-mediated topical delivery of plasmid DNA with cationic lipid nanoparticles to the skin.
Jin SE; Kim CK
Colloids Surf B Biointerfaces; 2014 Apr; 116():582-90. PubMed ID: 24631964
[TBL] [Abstract][Full Text] [Related]
14. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy.
Choi JU; Lee SW; Pangeni R; Byun Y; Yoon IS; Park JW
Acta Biomater; 2017 Jul; 57():197-215. PubMed ID: 28476587
[TBL] [Abstract][Full Text] [Related]
16. Improvement of skin wound healing in diabetic mice by kinin B2 receptor blockade.
Desposito D; Chollet C; Taveau C; Descamps V; Alhenc-Gelas F; Roussel R; Bouby N; Waeckel L
Clin Sci (Lond); 2016 Jan; 130(1):45-56. PubMed ID: 26443866
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate promotes wound healing response in diabetic mice by activating keratinocytes and promoting re-epithelialization.
Ning Y; Yuan Z; Wang Q; He J; Zhu W; Ren DN; Wo D
Phytother Res; 2024 Feb; 38(2):1013-1027. PubMed ID: 38140774
[TBL] [Abstract][Full Text] [Related]
18. Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators.
Nguyen PD; Tutela JP; Thanik VD; Knobel D; Allen RJ; Chang CC; Levine JP; Warren SM; Saadeh PB
Wound Repair Regen; 2010; 18(6):553-9. PubMed ID: 20955346
[TBL] [Abstract][Full Text] [Related]
19. Topical α-gal nanoparticles accelerate diabetic wound healing.
Kaymakcalan OE; Abadeer A; Goldufsky JW; Galili U; Karinja SJ; Dong X; Jin JL; Samadi A; Spector JA
Exp Dermatol; 2020 Apr; 29(4):404-413. PubMed ID: 32027409
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 induces fibroblast growth factor 21 in diabetic mice.
Furusawa Y; Uruno A; Yagishita Y; Higashi C; Yamamoto M
Genes Cells; 2014 Dec; 19(12):864-78. PubMed ID: 25270507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
